key: cord-0890813-r28hf45y
authors: Kumar, Deepali; Humar, Atul; Keshavjee, Shaf; Cypel, Marcelo
title: A call to routinely test lower respiratory tract samples for SARS‐CoV‐2 in lung donors
date: 2021-04-01
journal: Am J Transplant
DOI: 10.1111/ajt.16576
sha: 0083829281fe0c97bef5c252189c19ed34dc1e39
doc_id: 890813
cord_uid: r28hf45y

SARS-CoV-2 may be transmissible from organ donor to recipient, although only a single lung transplant case has been reported (1). The American Society of Transplantation (AST) has recommended deceased donor screening for SARS-CoV-2 with upper respiratory tract sampling for nucleic acid testing (NAT) within 72 hours of procurement (2, 3). Lower respiratory tract samples are recommended when feasible, although this practice is not consistent across OPOs. This is likely because current NAT assays are not validated for lower respiratory tract samples.

To the Editor:

SARS-CoV-2 may be transmissible from organ donor to recipient, although only a single lung transplant case has been reported. 1 The American Society of Transplantation (AST) has recommended deceased donor screening for SARS-CoV-2 with upper respiratory tract sampling for nucleic acid testing (NAT) within 72 h of procurement. 2, 3 Lower respiratory tract samples are recommended when feasible, although this practice is not consistent across OPOs. This is likely because current NAT assays are not validated for lower respiratory tract samples.

In February 2021, we (Toronto, Canada) accepted a lung offer from Pennsylvania. The donor suffered anoxic brain injury secondary to drug overdose. He was screened with two nasopharyngeal swabs (NPS) and had a normal CT chest. Since available information suggested that the likelihood of SARS-CoV-2 was low, a clinical decision was made to proceed. Second course of Remdesivir × 5 days Pulse methylprednisolone Cycle threshold (Ct) represents the number of PCR cycles needed for detection and is a rough surrogate marker for viral load with an inverse correlation (lower Ct values represent higher viral loads); Ct values in the range reported above represent a relatively strong positive PCR result and a moderate to high viral load, E gene is the envelope gene, R gene is the RNA-dependent RNA polymerase (RdRp) gene, N gene is the nucleocapsid gene. Ct values are provided for overall interpretation but are not required as part of donor screening. a NAT testing performed using the Seegene Allplex 2019 nCoV assay.

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

American Society of Transplantation. Recommendations and guidance for organ donor testing

Guidance from the ISHLT regarding the SARS CoV-2 pandemic

Consensus guidance for organ donation and transplantation services during COVID-19 pandemic